TrialJournal of Alzheimer's disease : JAD2020

Baseline Prevalence of Polypharmacy in Older Hypertensive Study Subjects with Elevated Dementia Risk: Findings from the Risk Reduction for Alzheimer's Disease Study (rrAD).

Eric D Vidoni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.